125 filings
Page 2 of 7
8-K
j1d80asah63won
29 Nov 23
Entry into a Material Definitive Agreement
8:10am
8-K
zlo7l 68gj
28 Nov 23
180 Life Sciences Announces Review of Strategic Alternatives
9:00am
8-K
lkl biv976f
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
pgxj2t5 nkt
18 Oct 23
Other Events
4:33pm
8-K
6prh8dee5tn4wrczg
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
zbhhs
28 Sep 23
Termination of a Material Definitive Agreement
4:18pm
8-K
m30fhmu0ab284f5q6ibx
22 Sep 23
Other Events
9:00am
8-K
5tq eu2d9kgjlz
8 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
es6uzwa jqwxw9zjcwq
7 Sep 23
Material Modifications to Rights of Security Holders
8:30am
8-K
8lmnw
15 Aug 23
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
4:31pm
8-K
4kx4ur94wjc84mdj
7 Aug 23
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
9:00am
8-K
gdmnwj3fy64s2 ht
3 Aug 23
Regulation FD Disclosure
8:00am
8-K
9wcd41rt673b nmk
31 Jul 23
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
8:00am
8-K
n3ioq7hcd9nzq0whqgh
10 Jul 23
Departure of Directors or Certain Officers
8:30am
8-K
gb0g6sd9qqg
28 Apr 23
Departure of Directors or Certain Officers
5:24pm
8-K
sjggqy
26 Apr 23
Other Events
8:00am
8-K
cax76rba2
10 Apr 23
180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement
4:30pm
8-K
y4xlccs19nm gg55d6
23 Feb 23
180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and Application
8:32am
8-K
8whv1cmywkhqnyjb
22 Feb 23
Regulation FD Disclosure
4:32pm
8-K
1b9ylf
16 Feb 23
Regulation FD Disclosure
2:50pm